close 74% of retail investor accounts lose money when trading CFDs with this provider. Investments involve risks and are not suitable for all investors. CFDs are complex instruments and come with a high risk of losing money rapidly due to leverage. 74% of retail investor accounts lose money when trading CFDs with this provider. You should consider whether you understand how CFDs work and whether you can afford to take the high risk of losing your money.
SearchSearch
Change languageEnglish (International)
Dashboard

LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

LLY

984.76

+0.73%↑

JNJ

241.59

-0.56%↓

ABBV

219.68

-2.45%↓

NVS

153.09

-0.73%↓

AZN

190.11

-0.92%↓

Home・Stock List・Inovio Pharmaceuticals Inc
Search

Inovio Pharmaceuticals Inc

Closed

SectorHealthcare

1.66 -0.6

Buy

Price update 13 Mar 2026, 19:59 UTC

BuySell

Overview

Share price change

24h

Current

Min

1.65

Max

1.67

Key metrics

By Trading Economics

Income

-22M

-45M

Profit margin

-30,140.489

Employees

134

Recommendations

By TipRanks

Recommendations

Buy

12 Months Forecast

+171.08% upside

Dividends

By Dow Jones

Next Earnings

12 May 2026

Market Stats

By TradingEconomics

Market Cap

101M

Previous open

2.26

Previous close

1.66

News Sentiment

By Acuity

70%

30%

313 / 351 Healthcare

Technical Score

By Trading Central

Confidence

Bullish Evidence

1.76 / 1.94 Support & Resistance

Inovio Pharmaceuticals Inc Chart

Past performance is not a reliable indicator of future results.

Related News

29 Dec 2025, 15:54 UTC

Major Market Movers

Inovio Shares Drop After FDA Says No Plans to Discuss INO-3107 Application

DJ

Read

Peer Comparison

Price change

Inovio Pharmaceuticals Inc Forecast

Price Target

By TipRanks

171.08% upside

12 Months Forecast

Average 4.5 USD  171.08%

High 6 USD

Low 3 USD

Based on 2 Wall Street analysts offering 12 month price targets forInovio Pharmaceuticals Inc - Dist in the last 3 months.

Rating Consensus

By TipRanks

Buy

2 ratings

1

Buy

1

Hold

0

Sell

Based on 2 analysts giving stock ratings to Inovio Pharmaceuticals Inc - Dist in the past 3 months.

Technical Score

By Trading Central

1.76 / 1.94Support & Resistance

Short Term

Bullish Evidence

Recent bullish events outweigh bearish events.

Intermediate Term

Strong Bullish Evidence

Recent bullish events outweigh bearish events.

Long Term

No Evidence

There are no events.

Sentiment

By Acuity

313 / 351 Healthcare

News Sentiment

Bearish Evidence

Volatility

Below average

News Volume (RCV)

Below average

Financials

Selling and administration expenses

Pre-tax profit

Sales

Interest expense on debt

Operating profit

$

Other stocks from the sector

LLY

Eli Lilly and Co.

984.76

↑ +0.73%

JNJ

Johnson and Johnson

241.59

↓-0.56%

ABBV

AbbVie Inc

219.68

↓-2.45%

NVS

Novartis AG

153.09

↓-0.73%

AZN

AstraZeneca PLC

190.11

↓-0.92%
help-icon Live chat